Insmed Inc. buy JPMorgan Chase & Co.
Start price
08.06.26
/
50%
€81.42
Target price
08.06.27
€155.21
Performance (%)
16.30%
Price
17.07.26
€94.51
Summary
This prediction is currently active. The prediction currently has a performance of 16.30%. This prediction currently runs until 08.06.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -6.426% | -6.426% |
| iShares Core DAX® | -1,11 % | -0,85 % |
| iShares Nasdaq 100 | -4,35 % | -5,76 % |
| iShares Nikkei 225® | -6,79 % | -10,34 % |
| iShares S&P 500 | -1,79 % | -0,33 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) had its price target lowered by JPMorgan Chase & Co. from $180.00 to $179.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat